- Home
- SIM vs SLNO Comparison
SIM vs SLNO Comparison
Compare SIM & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIM
- SLNO
- Stock Information
- Founded
- SIM 1969
- SLNO 1999
- Country
- SIM Mexico
- SLNO United States
- Employees
- SIM N/A
- SLNO N/A
- Industry
- SIM Steel/Iron Ore
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SIM Industrials
- SLNO Health Care
- Exchange
- SIM Nasdaq
- SLNO Nasdaq
- Market Cap
- SIM 4.2B
- SLNO 3.8B
- IPO Year
- SIM 1993
- SLNO 2014
- Fundamental
- Price
- SIM $27.79
- SLNO $87.26
- Analyst Decision
- SIM
- SLNO Strong Buy
- Analyst Count
- SIM 0
- SLNO 9
- Target Price
- SIM N/A
- SLNO $105.11
- AVG Volume (30 Days)
- SIM 1.8K
- SLNO 1.7M
- Earning Date
- SIM 07-29-2025
- SLNO 08-06-2025
- Dividend Yield
- SIM N/A
- SLNO N/A
- EPS Growth
- SIM 122.92
- SLNO N/A
- EPS
- SIM 3.34
- SLNO N/A
- Revenue
- SIM $1,641,713,837.00
- SLNO N/A
- Revenue This Year
- SIM N/A
- SLNO N/A
- Revenue Next Year
- SIM N/A
- SLNO N/A
- P/E Ratio
- SIM $8.41
- SLNO N/A
- Revenue Growth
- SIM N/A
- SLNO N/A
- 52 Week Low
- SIM $22.15
- SLNO $41.50
- 52 Week High
- SIM $31.00
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- SIM 51.75
- SLNO 61.04
- Support Level
- SIM $27.65
- SLNO $79.70
- Resistance Level
- SIM $28.80
- SLNO $88.62
- Average True Range (ATR)
- SIM 0.27
- SLNO 3.39
- MACD
- SIM -0.00
- SLNO -0.01
- Stochastic Oscillator
- SIM 43.44
- SLNO 73.63
About SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States. The maximum of its sales is from the Mexico segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.